Pathological interaction between diabetes mellitus and Alzheimer's disease

Japanese Journal of Neuropsychopharmacology

Volumn 32, Issue 5-6, 2012, Pages 239-244

  Takeda, Shuko ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Amyloid beta; Diabetes mellitus; Diagnostic marker; Insulin

Indexed keywords

AMYLOID BETA PROTEIN; GLUCOSE; INSULIN;

ALZHEIMER DISEASE; BRAIN DAMAGE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE MODEL; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID; ANIMALS; DIABETES COMPLICATIONS; DISEASE MODELS, ANIMAL; HUMANS; INSULIN;

EID: 84871831927     PISSN: 13402544     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Beeri, M. S., Silverman, J. M., Davis, K. L., Marin, D., Grossman, H. Z., Schmeidler, J., Purohit, D. P., Perl, D. P., Davidson, M., Mohs, R. C. and Haroutunian, V. (2005) Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci, 60: 471-475. (Pubitemid 40712864)
2. Chiu, S. L., Chen, C. M. and Cline, H. T. (2008) Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo. Neuron, 58: 708-719.
3. Deane, R., Wu, Z. and Zlokovic, B. V. (2004) RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke, 35: 2628-2631. (Pubitemid 39458354)
4. Gasparini, L. and Xu, H. (2003) Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends Neurosci, 26: 404-406. (Pubitemid 37288973)
5. Hardy, J. and Selkoe, D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 297: 353-356. (Pubitemid 34790756)
6. Janson, J., Laedtke, T., Parisi, J. E., O'Brien, P., Petersen, R. C. and Butler, P. C. (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes, 53: 474-481. (Pubitemid 38174565)
7. Kalaria, R. N. (2009) Neurodegenerative disease: Diabetes, microvascular pathology and Alzheimer disease. Nat Rev Neurol, 5: 305-306.
8. Matsuzaki, T., Sasaki, K., Tanizaki, Y., Hata, J., Fujimi, K., Matsui, Y., Sekita, A., Suzuki, S. O., Kanba, S., Kiyohara, Y. and Iwaki, T. (2010) Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama study. Neurology, 75: 764-770.
9. Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A., Hofman, A. and Breteler, M. M. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 53: 1937-1942.
10. Peila, R., Rodriguez, B. L. and Launer, L. J.; Honolulu-Asia Aging Study (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes, 51: 1256-1262. (Pubitemid 34438377)
11. Profenno, L. A., Porsteinsson, A. P. and Faraone, S. V. (2010) Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry, 67: 505-512.
12. Sato, N., Takeda, S., Uchio-Yamada, K., Ueda, H., Fujisawa, T., Rakugi, H. and Morishita, R. (2011) Role of insulin signaling in the interaction between Alzheimer disease and diabetes mellitus: A missing link to therapeutic potential. Curr Aging Sci, 4: 118-127.
13. Takeda, S., Sato, N., Ogihara, T. and Morishita, R. (2008) The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: New therapeutic potential. Front Biosci, 13: 2253-2265. (Pubitemid 351589250)
14. Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H. and Morishita, R. (2009) Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse models. Biochem Biophys Res Commun, 385: 193-197.
15. Takeda, S., Sato, N., Uchio-Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H. and Morishita, R. (2010a) Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes. Proc Natl Acad Sci USA, 107: 7036-7041.
16. Takeda, S., Sato, N., Rakugi, H. and Morishita, R. (2010b) Plasma beta-amyloid as potential biomarker of Alzheimer disease: Possibility of diagnostic tool for Alzheimer disease. Mol Biosyst, 6: 1760-1766.
17. Takeda, S., Sato, N., Rakugi, H. and Morishita, R. (2011) Molecular mechanisms linking diabetes mellitus and Alzheimer disease: Beta-amyloid peptide, insulin signaling, and neuronal function. Mol Biosyst, 7: 1822-1827.
18. Takeda, S., Sato, N., Uchio-Yamada, K., Yu, H., Moriguchi, A., Rakugi, H. and Morishita, R. (2012) Oral glucose loading modulates plasma β-amyloid level in Alzheimer's disease patients: Potential diagnostic method for Alzheimer's disease. Dement Geriatr Cogn Disord, 34: 25-30.
19. Xu, W., Qiu, C., Winblad, B. and Fratiglioni, L. (2007) The effect of borderline diabetes on the risk of dementia and Alzheimer's disease. Diabetes, 56: 211-216.